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Abstract
The blood pressure is an important factor in the diagnosis and evaluation of several
diseases, such as acute myocardial infarction and stroke. This way, continuous monitor-
ization of this parameter is crucial to a correct health evaluation. The current methods,
like the oscillometric method, have some major drawbacks, that can influence the output
values or even make the measurements impossible. One example is the high frequency
evaluation of the blood pressure, in the standard used methods the process of measuring
can take up to 3 minutes, and a waiting time is necessary between consecutive measure-
ments.
This dissertation presents two different cuffless solution to solve those problems. One
based on physical models of the human body, and the other using machine learning
techniques.
In the first solution seven models that correlate pulse transit time and blood pressure,
deducted by different authors, were tested to evaluate which one performed better. The
testes were performed in a custom dataset acquired at Fraunhofer AICOS and in clinical
environment, with two different devices (low cost device and medical grade device). The
results indicate that pulse transit time can be used to track blood pressure, the developed
device/method was evaluated as grade A based in the Standard IEEE 1708-2014.
The second solution it’s a proof of concept using a public database and three different
machine learning methods (Random Forest, Neural Network and AdaBoost). Two sets
of features are calculated from the ECG and PPG signals, one using TSFEL (spectral,
frequency and time domain features) and a total of 15 custom features. The proposed
method outperforms the methods presented in bibliography with mean absolute error of
3.6 mmHg and 2.0 mmHg to systolic and diastolic blood pressure respectively.
Keywords: Blood Pressure, Cuffless, Machine Learning, Physiological Models, Photo-
plethysmography, Electrocardiogram, Signal Processing
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Resumo
A pressão arterial é um fator importante no diagnóstico e avaliação de diversas do-
enças, como o enfarte agudo do miocárdio e o ataque cardíaco. Assim, uma avaliação
contínua deste parâmetro é fundamental para uma boa avaliação clínica. Os métodos
atuais, como o método oscilométrico, apresentam algumas desvantagens, que podem in-
fluenciar e/ou impossibilitar a medição da pressão arterial, um exemplo disso é a medição
da variações rápidas deste parâmetro fisiológico. Nos métodos comumente utilizados, o
processo de medição pode demorar até 3 minutos e um período de espera entre medições
é bastante aconselhado.
Nesta dissertação são apresentadas duas soluções para resolver estes problemas, um
tendo como base modelos do corpo humano, e outro usando técnicas de machine learning.
Na primeira solução, sete modelos deduzidos por diferentes autores, foram testados
para avaliar qual deles apresenta melhor desempenho. Os testes foram realizados num
conjunto de dados adquiridos na Fraunhofer AICOS e em ambiente clínico, com dois
dispositivos diferentes (dispositivo de baixo custo e dispositivo de grade médico). Os
resultados indicam que o tempo de trânsito do pulso pode ser usado para estimar a
pressão arterial. O dispositivo/método desenvolvido foi avaliado com grau A com base
no standard IEEE 1708-2014.
A segunda solução é uma prova de conceito usando a base de dados MIMIC III e
três métodos diferentes de aprendizagem automática (Random Forest, Redes neuronais
e AdaBoost). Dois conjuntos de features são calculados a partir dos sinais de ECG e PPG,
um usando TSFEL (features de domínio espectral, frequência e tempo) e um total de 15
features personalizadas. O método proposto apresenta resultados superiores aos métodos
descritos na bibliografia com erro médio absoluto de 3,6 mmHg e 2,0 mmHg referente,
respetivamente, à pressão arterial sistólica e diastólica.
Palavras-chave: Pressão Arterial, Aprendizagem Automática, Modelos Fisiológicos, Foto-
pletismografia, Eletrocardiograma, Processamento de Sinais
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1
Introduction
The health care subject and the technology in medicine have increasingly gain importance
in the society. One of the objectives (and trends) in the biomedical investigation field is
to develop mechanisms and technology that can push diagnostic and treatment forward,
and make them easier and available for the masses.
In this chapter several topics will be addressed to explain and present the importance
and need of a new method to measure the BP without a cuff.
1.1 Context and Motivation
The high blood pressure (HBP), also called hypertension, is a significant risk factor in
several cardiovascular diseases [1], such as acute myocardial infarction and stroke. Ac-
cording to data from the World Health Organization, it is estimated that 13% of the
world’s deaths are directly or indirectly linked to HBP, compared to 9% associated with,
smoking [2]. In Portugal, the numbers are very worrying, given that it is estimated that
approximately 36% of the population suffers from hypertension [3].
The BP measurement is therefore essential throughout the diagnostic and evaluation
process of hypertension, and the control of this parameter is fundamental during surg-
eries and in ambulatory. Currently, the most commonly used and the gold standard
method is auscultation using a mercury sphygmomanometer or an electronic equivalent.
By hearing the Korotkoff sounds, it is possible for the physician to identify the systolic
blood pressure (SBP) and diastolic blood pressure (DBP) [5]. The measurement of BP
through the method described above is simple and presents values, in most cases, suf-
ficient for a correct diagnosis [6]. However, there are some limitations inherent to this
method, such as the discomfort associated with increased pressure in the cuff, which may
1
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over 33
Figure 1.1: Prevalence of raised BP, aged 18+ years, males, 2014, Europe, adapted from
[4]
lead to the incorrect BP measurements due to the patient’s stress conditions [7], the im-
possibility of realizing continuous beat-to-beat measurements to evaluate high frequency
changes in BP, since the whole process of inflation, deflation, and stabilization can take
between one and two minutes [8, 9], or even the presence of the physician/ nurse, that
can lead to a white coat hypertension condition. This is a phenomenon that affects 15%
to 30% of the subjects [10], and it is characterized by an abnormal increase in BP only in
clinical environment, that can contribute to a false positive hypertension diagnosis. It is
also difficult to measure BP during sleep since the patient can be awakened due to infla-
tion of the cuff, which means that the values are not representative of what is intended to
be evaluated [9].
Some of this limitations can be solved by measuring intra-arterial pressure (IAP). Such
a procedure involves the insertion of a catheter into the artery, usually the radial artery
[11] and the measurement of the BP continuously. Since this is an invasive method, it is
associated with the usual risks of this kind of procedures, such as infection and thrombi
formation [11], but also pain and discomfort.
Due to technology development, other methods to measure BP based on pulse transit
time (PTT) and pulse wave velocity (PWV) attempt to solve these gaps in the currently
used methodologies, so that a all place, correct, continuous and comfortable BP measure-
ments are possible.
1.2 Objectives
The objective of this dissertation is to develop a system/method to estimate BP without
the cuff that is usually used in the current methods.
Two different approaches have been proposed during the years, one based on the
2
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physical modulation of the blood flow in the arteries, and the other base on machine
learning techniques. This work aims to evaluate the differences between these two ap-
proaches, and compare them with previous works in the area. Several sub-objectives can
be identified in both parts of this work:
• Physical Models: It can be decomposed in four different, but not independent
phases. The first phase is the setup of the acquisition system, some important
aspects should be tested, like which physiological signals to acquire, the accuracy
and scalability of the system, and the possibility to be adapted to a current day-to-
day use by everyone in different environments and situations. Two systems with
different price points are also evaluated in this dissertation, a low cost device and
a medical grade device, to evaluate the influence of the acquisition system in the
overall accuracy. The second phase is the signal acquisition and processing phase,
at this stage is important to identify some sub objectives, like for example, the sig-
nals digital filtering, the test of different algorithms to automatic identify important
fidutial points in the acquired physiological signals and implementation of the al-
gorithm to calculate PTT. The third phase consists of the BP estimation algorithms
implementation, the objective is to use the pairs (PTT,BP) to train different mod-
els deducted using physical properties of the blood flow in vessels and use those
models to predict future values of BP. The fourth and last phase is data acquisition
procedure, the objective is to acquire good quality data that will be used to evaluate
each system and model. Several factors need to be taken into account and studied,
like the procedure to vary the BP in the calibration process and the acquisition
protocol.
• Machine Learning: This approach will be developed as a proof of concept, with
the objective of testing the BP estimation possibility based in machine learning
techniques.
The expected output will be the order of magnitude of the measurement error of dif-
ferent cuffless BP estimation methods against the cuff-based methods. This work should
provide useful information for future projects related to the cuffless BP measurements.
1.3 Applications
The work developed in this dissertation has the possibility to be used in several aspects
of the medical and biomedical field.
One strong example is the growth in the demand of wearable devices that evaluate
health and physical condition during the day or during physical activities. The most
common devices use several sensors to give the user usefull information like number of
steps, active time, travelled distance, heart rate, stress level, oxygen saturation and, more
recently, the ECG signal. A method to passively measure the BP without using a cuff can
3
CHAPTER 1. INTRODUCTION
be implemented in this format allowing the user to track this important parameter of his
health.
This method can also be a better and more comfortable approach to measure BP in a
ambulatory scenario, since the normal devices to measure this physiological parameter in
this conditions are relatively bulky, uncomfortable and can influence the measurements
in some conditions, like during sleep, where the inflation and deflation of the cuff can
wake up the subject.
1.4 Thesis Outline
This work is structured as follows:
• Chapter 2: The objective of this chapter is to present and explain with sufficient
detail, concepts that are useful to a complete understanding of this dissertation,
like the definition of the BP concept, the origin on the PPG and ECG signal, among
others;
• Chapter 3: The objective of this chapter is to describe the materials and methodolo-
gies used in the physical model approach to estimate BP
• Chapter 4: Just like in chapter 3, the objective of this chapter is to describe materials
and methodologies used to estimate BP using machine learning.
• Chapter 5: The core objective in this chapter is to compare both models, make
considerations, and propose future adaptations that can be implemented in the
future to improve the process of BP estimation without cuff.
4
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Background Concepts
TO a correct understanding of this work it is important to define and explain several
definitions, and concepts. This includes the definition of BP, explanation of some physio-
logical signals, algorithms to detect important points in those signals, machine learning
methods, among others.
2.1 Blood Pressure
2.1.1 Definition
In a general sense, the pressure is a force per unit area, so BP is defined as the force that
blood exerts in blood vessels inner walls divided by area of that vessel’s inner walls. The
maximum pressure occurs during ventricular systole and is called systolic blood pressure
and the minimum pressure occurs during ventricular diastole and is called diastolic
blood pressure (Figure 2.1). The mmHg unit (millimeters of mercury) is commonly
used in medicine rather than the SI unit, the pascal. As the name indicates a pressure
corresponding to 120 mmHg would be equal to the pressure felt at the column base with
120 mm of mercury height. It is important to note that blood pressure measurement is
measured in relation to atmospheric pressure [12].
Therefore the BP varies continuously during the blood flow as shown in Figure 2.1,
two pressure points have especial relevance for medical diagnosis, the SBP, that is the
maximum pressure that occurs during systole, and DBP, that is the minimum pressure
that occurs during diastole.
5
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Figure 2.1: Continuous BP signal
2.1.2 Mean Arterial Pressure
The mean arterial pressure (MAP) is a critical hemodynamic factor, fundamental for
a correct evaluation of blood perfusion in critically ill patients [13]. The MAP can be
estimated with SBP and DBP, through equation 2.1 [14].
MAP =
2
3
DBP +
1
3
SBP (2.1)
2.1.3 High blood pressure
The table 2.1 summarizes the BP classification for adults, according to data from the
European Society of Hypertension.
Different organizations define their own classes of BP classification values, and be-
cause of this factor it is common to find slightly different values and/or classifications.
2.1.4 Pulse Pressure
The PP is defined as the pressure difference between the SBP and the DBP (Figure: 2.2)
and it is influenced mainly by two factors, stroke volume and vascular compliance [17].
The pulse of pressure caused by the blood output from the heart, associated with
the elastic properties of the arteries, leads to the distension of these vessels so as to
temporarily accommodate the ejected blood, storing energy that is subsequently used for
6
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Figure 2.2: BP along the different blood vessels, and representation of MAP and the pulse
pressure (PP) [15]
Table 2.1: Reference BP values according to the ESH [16]
Classification SBP (mmHg) DBP (mmHg)
Great <120 AND <80
Normal 120 to 129 OR 80 to 84
Normal High 130 to 139 OR 85 to 89
Hypertension grade 1 140 to 149 OR 90 to 99
Hypertension grade 2 150 to 179 OR 100 to 109
Hypertension grade 3 > 180 OR > 110
the blood movement maintenance in the diastolic phase, ensuring a relatively continuous
blood flow in the tissues [18].
This momentary increase in the artery volume can be detected in various body parts,
such as the common carotid artery, the radial artery, among others, simply by the palpa-
tion method.
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2.1.5 Traditional Methods to Measure Blood Pressure
To understand the differences between the proposed methods in this work and the com-
monly used methods it is important review the most common tradional method to mea-
sure the BP.
2.1.5.1 Invasive method
Invasive blood pressure monitoring is a technique that involves a direct blood pressure
measurement inside an artery, commonly used during surgeries or in the Intensive Care
Unit. A catheter needs to be placed inside the patient’s artery, usually brachial, radial or
femoral artery and connected to an electronic pressure sensor.
This method is considered the most accurate method to measure blood pressure [19],
and, more important, to do a continuous beat-to-beat measurement of the value with a
correct visualization of the signal waveform, useful, for example, in vascular surgeries.
Since it is an invasive process, there is a risk of some complications, like infection, pain,
thrombosis, bleeding, and others.
2.1.5.2 Palpatory method
The palpatory method is a simple method that can be used to estimate systolic blood
pressure. The cuff is placed on the patient arm and inflated until the pressure inside the
cuff is 30 to 40 mmHg higher than pressure where no pulse can be felt, then the cuff is
slowly deflated, the systolic pressure is the pressure point where pulse wave can be felt
again.
This method requires tactile sensibility and experience by who performs it, and it
usually underestimates the systolic blood pressure.
2.1.5.3 Auscultatory method
In this noninvasive method a cuff is connected to a manometer and is placed around the
patient’s arm, just above the elbow, and a stethoscope is held in a distal position over the
brachial artery.
The BP measurement using mercury sphygmomanometer is considered the gold stan-
dard in the subject, however, this kind of sphygmomanometer is being discontinued, and
their use discouraged due to the harmful characteristics of mercury.
Aneroid manometers came as a solution to this problem because no mercury is used.
They have a purely mechanical mechanism with metal bellows that expand when the
pressure in the cuff increases [20]. This mechanism has some drawbacks: it is just accu-
rate if adequately calibrated [21], needs maintenance every six months, and needs to be
handled gently, because it is easily de-calibrated [20]. This sort of devices is, in general,
less accurate than mercury sphygmomanometers.
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More recent developed sphygmomanometers, called hybrid sphygmomanometers, use
a mix of both electronic and auscultatory features [22]. In this genre of devices, the
mercury column is replaced with an electronic pressure gauge, and BP is taken in the
same process as with the other two devices, having the advantage that any terminal digit
preference (when the observer rounds of a measurement) are made [22].
BP measurement using the auscultatory method follows the following steps:
• The cuff is inflated until the pressure inside the cuff exceeds the pressure in the
artery, leading to a total collapse of the brachial artery, at this point no sound can
be heard in the stethoscope because blood cannot flow through the area constricted
by the cuff.
• Then the pressure is slowly reduced
• At some pressure point, a periodic sound can be heard in the stethoscope, known
as Korotkoff sounds. They result from the vibration produced by the flowing blood
in the semi constricted area. It is important to note that Korotkoff sounds change
tone and loudness with the pressure reduction inside the cuff [20], five phases can
be usually identified, phase I, associated with clear tapping sound start, phase II,
when the sounds become softer and more extended, phase III, defined when the
sounds become crisper and louder, phase IV, when the sounds become muffled and
softer, and phase V, when no sound can be detected [23].
• Several studies conclude that the pressure related to the starting sound in phase I is
associated with systolic pressure, however, the value usually is lower than the real
physiological value [24]. Therefore, systolic pressure tends to be underestimated.
• Phase V can be linked to diastolic blood pressure, but usually, the measured value
is higher when compared to intra-arterial pressure [24].
Despite the BP differences between auscultatory method and intra-arterial method,
the auscultatory method provides adequate data for various applications in medicine.
However, it has some drawbacks that limit the use of this technique in some specific
situations. First, it is not possible to do a continuous measurement, since the procedure
of inflation and deflation, take some time. A second measurement should not be done
right after the first one. To avoid errors in the measurement is necessary to do a pause of
one or two minutes between them [25], because of this, a short-term study in BP variation
is not possible. Long-term studies, mainly during the night, are also hard to implement,
since the process (inflation and deflation of the cuff) will probably disturb the patient,
and the value measured do not represent the true BP value at that time. Another problem
is the influence of the measurement itself or the ambient where it is made, on the patient’s
blood pressure [9].
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2.1.5.4 Oscillometric method
The oscillometric method, employed by most clinical-grade automated BP devices, takes
advantage of cuff pressure variations that append due to the blood pressure itself. This
method was first demonstrated in 1876 by the French scientist Étienne-Jules Marey in
“Pression et vitesse du sang”.
In this method, just like in the auscultatory method, the cuff is inflated until the
pressure is higher than systolic pressure, then it is slowly deflated to a sub- diastolic
pressure level. The pressure signal inside the cuff is recorded during deflation and then
filtered to remove the low-frequency component. Several studies indicate that the point
of maximum oscillation appears to provide an acceptable value to the mean arterial
pressure [26]. Systolic and diastolic blood pressure can be estimated using mean arterial
pressure and empirically derived algorithms and oscillometric models, such as the fixed-
ratio method [27].
This method has some advantages when compared with auscultatory one [23]:
• The person that is doing this evaluation does not need to know the exact location
of the brachial artery since no sound needs to be heard. Therefore, the patient can
do it alone in ambulatory;
• The possibility to be used in patients with muted Korotkoff sounds;
• It is less susceptible to external noise.
However, this technique has some disadvantages, such as mean arterial pressure un-
derestimation in patients with stiff arteries and wide pulse pressures. This happens
because oscillations amplitude have a direct correlation with these factors [23]. Other
disadvantages can be pointed out, as the high sensitivity to motion artifacts [23] and, in
some cases, reduced accuracy due to the empirical estimations of systolic and diastolic
blood pressure.
2.1.5.5 Ultrasound technique
This method, proposed in 1965 by Ware, is based on the Doppler effect. This physical
phenomenon can be explained as a change in a wave frequency when the font has a
relative motion to an observer. The Doppler effect can be used to obtain a systolic and
diastolic blood pressure, this last one with higher uncertainty [28].
Just like in oscillometric, auscultatory and palpatory method, an inflatable cuff is
placed around patient harm, with an ultrasound transducer over the brachial artery, the
cuff is then inflated until the artery collapse, at this point, since there is no blood flowing
through the vessel, any change in frequency can be detected, because the artery wall is
not in motion. Thereafter the cuff pressure is slowly deflated, at the precise moment that
cuff pressure becomes smaller than systolic pressure, the artery opens with high velocity
[29], this motion causes a start in the ultrasound frequency shift signal. When the cuff
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pressure falls below diastolic pressure, a characteristic muffled signal can be detected
in the ultrasound frequency shift signal, “marking” the diastolic pressure [29]. After
that other high-frequency signals can be detected due to the usual wall motion caused by
wave pressure [29].
Ultrasound technique can be used to measure, with good accuracy, systolic blood
pressure value in infants and children, as well as in patients with faint Korotkoff sounds
[23].
2.1.5.6 Vascular unloading method
This method, also known as Finapres (from FINger Arterial PRESsure), the name of
the commercial equipment, based in the work of Czech physiologist Jan Peñáz, uses the
infrared light transmission to measure blood pressure in the finger [23].
A cuffwith a photo-plethysmograph is placed around the finger, and a first calibration
is made [30]:
1. The cuff is inflated until a pressure level below normal blood pressure (Pi);
2. The photo-plethysmograph signal is recorded during several cardiac cycles (I(t));
3. The cuff pressure (Pi) is increased in small increments, and the point 2 repeated to
each pressure;
4. The cuff pressure is then fixed to the pressure value that maximize the I(t) ampli-
tude, and the mean light intensity (Imean) is calculated over several heart cycles.
Then the measurement process begins, a pressure servo regulator dynamically changes
Pi so that the Imean stays constant, the pressure inside the cuff represents the blood pres-
sure at that time. Several studies support the high correlation between the cuff pressure
Pi and the blood pressure at that time [30, 31].
This method makes possible the blood pressure measurement in real time in a non-
invasive way. However, this equipment is typically used scientific research because of the
high retail price, around 40 000 US dollars.
2.1.5.7 Tonometry
Just like the vascular unloading method, the tonometry can measure in a not invasive and
continuous way the blood pressure. In this technique, the artery (usually radial artery
[32]) is flattened due to a force applied by a cuff, or a strap, without occlusion. The artery
should be supported from below by a bone [33] (typically the radial bone [32]).
A force sensor or an array of sensors can be used to measure the force applied by the
artery wall. This force has a direct correlation with intra-arterial blood pressure when
some specific conditions are satisfied [32]:
• The artery us supported by the bone or other hard structure;
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• The artery cannot be occluded, if this happens the measurement will be erro-
neous[33];
• The artery wall thickness is much larger than the skin thickness;
• The artery wall beaves like an ideal membrane, where only the tensile force is
transmitted;
• The arterial rider (Figure 2.3) is smaller than the flattened area and is centered over
it;
• And the string constant of the transducer is much higher when compared with
artery string constant.
In these conditions, theoretically proved [34], the force signal is directly proportional to
intra-arterial blood pressure.
Figure 2.3: Schematic diagram of a tonometer sensor and a superficial artery [32]
This method has some important limitations, first, it measures peripheral pressure
instead of more centrally-located pressures, this can lead to erroneous measurements in
hypertensive patients with stiff arteries. Other disadvantages are:
• The sensitivity of the method to the sensor location;
• The need of calibration, the artery flattening degree depends on the hold down-
force, and it is essential to a correct tonometric pressure measurement [32];
• Retail price is too high to be a standard method.
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2.2 Electrocardiogram
The cardiac activity is closely linked to the creation and propagation of electrical action
potentials. The electrocardiogram, or ECG, is a measure of the change in the heart
electrical activity over time as the action potentials propagate in this same organ [35].
Due to the sequential depolarization and the contraction (which leads to movement) of
the zone where the depolarization occurs, zones with opposite charges are created and
can be analyzed as an electric dipole (Figure 2.4).
Figure 2.4: Hearth dipole formation [35]
The electric dipole formation in a conductive medium leads to an electric current
creation that causes a change in the electric field. Changes that can be measured by
placing electrodes on the surface of the body. The measured voltage depends on the
electrode orientation in relation to the electric dipole at that point.
2.2.1 Electrocardiogram signal shape
The ECG signal is represented as a potential difference, usually in milivolts (mV), in order
of time, usually represented in seconds (s). An example of the first lead (Lead I) ECG
signal is shown in Figure 2.5.
The signal portion for each heart beat is easily identifiable (Figure 2.6)
The signal in the figure 2.6 results from the sum of the various action potentials that
are created in various regions of the heart at different times. Because of that the ECG
signal is a crucial medical factor in the cardiovascular system evaluation.
In a normal ECG signal it is possible to identify five characteristic points. The signal
begins with a P wave (positive in leads I, II, and III) that results from the depolarization of
the two atria, followed by the QRS complex (after an isoelectric segment or PR segment)
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Figure 2.6: One ECG signal cycle
that results mainly from the ventricles depolarization and in a lower scale from the repo-
larization of both atria, and finally the T wave as a result of the ventricular repolarization.
In some specific conditions a low amplitude wave can appear in the ECG signal (U wave).
Since the QRS complex is normally the most visually identifiable portion of ECG trace
due to the bigger amplitude, it is usually used in the majority of the algorithms to identify
each heart beat. As previously mentioned the QRS complex, more specifically the R peak,
can be used as a proximal time reference point to calculate PTT.
2.2.2 Electrodes positioning
The electrodes positioning is a crucial factor in the obtained ECG signal since different
electrodes position configurations result in slightly different signals. Figure 2.7 shows
the standard electrode configuration for 12 leads (10 electrodes).
The use of several leads allows an analysis of the cardiac electrical dipole in differ-
ent directions, both in the vertical plane (through the peripheral electrodes) and in the
horizontal plane, through the precordial electrodes.
14
2.2. ELECTROCARDIOGRAM
(a) Limb electrodes location (b) Precordial electrodes location
Figure 2.7: Electrodes standard locations, adapted from [36]
2.2.3 R Peak Detection Algorithm
Several algorithms to do an automatic detection of the R peak have been proposed
throughout the years.
In 2002, Patrick Hamilton proposed and provided an open source algorithm do detect
R peaks in the ECG signal [37]. The algorithm can be described in five different phases:
1. The signal is digital filtered with a low cutoff frequency of approximately 8 Hz and
an high cutoff frequency of 16 Hz;
2. Differentiation and rectification of the signal;
3. Filter the signal with a 80 ms moving average filter;
4. Peaks detection;
5. Peaks correction.
The rules used to correct the detected peaks were defined empirically using physio-
logic limits the human body [37]:
• Ignore peaks that precede or follow larger peaks within 200 ms window;
• In the peak location check if the ECG signal has a positive and a negative slope. (To
remove identified peaks that result from base line shifts);
• If the detected peak occurs in a 360 ms window after the previous peak and if the
maximum slope is less than half when compared with the maximum slope of the
previous peak, consider it a T wave peak;
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• If the peak is larger than the detection threshold (adaptive threshold calculated
based in estimates of the previous QRS peak and noise peak heights) is classified as
a R peak, otherwise it is classified as a noise peak;
• If an interval equal to 1.5 times the mean RR interval has elapsed since the most
recent detection, within that interval there was a peak that was larger than half the
detection threshold, and the peak followed the preceding detection by at least 360
ms, classify that peak as a R peak.
The overall accuracy of this beat detector is close to 99.8% on the MIT/BIH and AHA
arrhythmia databases [37].
2.3 Photoplethysmography
The PPG is a practical and straightforward optical method commonly used to detect
changes in blood volume in the microvascular tissue bed [38].
2.3.1 Physical mechanism
The engineering underneath PPG is relatively simple, the device has a light source, that
emits light into the tissue, and a photodetector, the receptor of light that interacted with
that tissue. The photodetector can be placed adjacent to the light source in reflection
mode PPG or in the opposite side (transmission mode PPG) [39]. Usually the light source
depends on the objective, infrared light or near infrared light emitting diode are com-
monly used to measure blood flow that is more deeply concentrated in some parts of the
body, and green light emitting diodes are usually used to calculate oxygen absorption in
tissue, because radiation with that wavelength interacts differently with oxyhemoglobin
and deoxyhemoglobin [40]. Another important point is the influence of light wavelength
in PPG signal since penetration depth has a direct correlation with the wavelength of
the light that is being used. As a consequence, light with a larger wavelength penetrates
deeper in the skin (Figure 2.8) [39].
2.3.2 PPG waveform
The signal from PPG has two major components, an AC component, also called pulsatile,
that comse from blood volume variation that arises from heartbeat, and a DC compo-
nent (or almost DC), as a result of the presence of the tissue itself and from the average
blood volume, this last component is influenced by respiration cycle, sympathetic ner-
vous system and thermoregulatory processes [40], that causes low frequency changes in
the signal.
As already said, the AC component of the PPG signal is caused by the heart activity
and has a direct correlation with the heart’s systolic and diastolic phase. That way, the
PPG pulse can be divided into two portions, the first rising edge, between the valley and
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Figure 2.8: Mean penetration depth in order of light wavelength [41]
the pulse wave systolic peak, that represent systole, called anachrotic phase, and the next
falling edge, also known as catacrotic phase, characterized by diastole. A notch (called
dicrotic notch) could usually be identified in catacrotic phase because of the momentary
increase in blood volume due to retrograde flow. (Figure 2.9) [42]. The temporal delay
between the systolic peak and diastolic peak in the PPG signal, as well as the temporal po-
sition of the dicrotic notch are influenced by several factors, like the large artery stiffness,
that normally is higher in older people [43]. Because of this factor the PPG waveform has
slight differences between subjects.
2.4 Pulse Transit Time
The PTT is the time that the pressure wave created in the heart takes to travel between
two different arteries sites. Several studies indicate that PTT is closely linked to BP values
and can be used to estimate this physiological parameter due to vascular tone changes
that result from variation in BP.
An acute rise in BP lead to an increase in vascular tone, the arterial wall becomes
stiffer, lowering the pressure wave travel time (PTT). In the other hand, when the BP falls,
the vascular tone decreases causing a rise in PTT.
Although it is not possible to directly correlate the absolute value of the PTT signal
with absolute values of BP, it is possible to predict the variation of this parameter with
PTT. This indicates that a process of calibration is usually needed when using PTT to
estimate BP.
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Figure 2.9: PPG signal cycle example
2.4.1 PTT calculation
Several methods can be used to calculate PTT, the most obvious is to use two PPG sensors
in different positions, like finger and forearm or wrist and finger to detect the blood
volume variation on both positions, the PTT is the time interval between correspondent
positions in both signals. This approach is the most accurate among non invasive methods,
but has some major disadvantages. Due to the PPG nature, this signal is very prone to
motion artifacts that can lead to an impossible processing. Moreover, since the PPG
needs to be acquired in positions with superficial blood vessels. The signals acquired in
locations like arm and wrist have generally low signal to noise ratio or can not be detected
in some cases.
To overcome this disadvantages it is usual to use the R peaks of the ECG as proximal
time reference and finger PPG as distal time references to calculate the pulse arrival
time (PAT). It is the sum of the pre-ejection period (PEP) (delay between the ventricular
depolarization and the blood flowing from the heart) and PTT.
PAT = P EP + P T T (2.2)
Several studies indicate that PAT can be used as a substitute of PTT in BP estimation
with slightly worst results but with a setup that can be applied outside of the laboratory
[44–46]. In most studies in this area, the term PTT is commonly used as synonym of PAT
since use the setup ECG plus PPG lead to a much simple system to use in a day-to-day
basis when compared with systems with two PPG or one PPG sensor and one microphone
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in the chest (phonocardiogram).
Another important factor is the selection of the time point in the PPG signal to use as
distal time reference for PTT. Three points are commonly used for this purpose, the onset
point (systolic rising edge point where occurs the maximum variation) that leads to onset
pulse transit time (PTTonset), the position of the maximum that leads to maximum pulse
transit time (PTTmax), and the PPG cycle beggining that leads to initial pulse transit time
(PTTinit).
2.4.2 Blood Pressure Relation
Most of the models that correlate BP and PTT come from Moens-Korteweg equation and
Hughes equation or using empirical models.
The Moens-Korteweg equation [47] correlates the PWV with the vessel wall elastic
modulus (Equation 2.3).
PWV =
√
Eh
2ρri
(2.3)
Where E is the arterial wall Young’s modulus, h is the wall thickness, ρ is the blood
density, and ri is the artery internal radius.
Hughes et all. recognised that the elastic modulus of the vessel increases exponentially
with increasing blood pressure [48] (Equation 2.4).
E = E0e
−λP (2.4)
Where E is the elastic modulus of the wall, E0 is the elastic modulus at zero pressure,
P is the blood pressure and λ a coefficient that depends on the particular vessel.
Using equation 2.3 and equation 2.4 and knowing that PWV is inversely proportional
to PTT
PWV ∝ 1
P T T
(2.5)
It is possible to conclude that [48],
P = −1
λ
log
2k2ρri
E0h
+
1
λ
logP T T (2.6)
Where k is a constant.
The equation 2.6 can be visually simplified replacing all constants with constant A
and B. The final result is equation 2.7.
P = A+B× logP T T (2.7)
On the other hand, knowing that [49]
∆P = E
2∆r
ri
(2.8)
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And using equation 2.3 and 2.8 gives equation 2.9.
P =
A
P T T 2
+B (2.9)
Where A and B are subject dependent constants, but different from equation 2.6
constants.
Several other models based in empirical observations have been used in this area,
some of them using not only PTT but also other parameters like heart rate (HR). The
table 2.2 resumes the physical models used in bibliography.
Table 2.2: Physical Models
Ref. Model HR use
[49] A · P T T +B -
[50] AP T T 2 +B -
[51] A · logP T T +B -
[52, 53] AP T T +B -
[54] A · P T T 2 +B -
[54] A · P T T 2 +B · P T T +C -
[55] A · P T T +B ·HR+C X
[56] A · logP T T +B · logHR+C X
2.5 Machine Learning
Machine learning and artificial intelligence are terms that, nowadays, can be found in
several applications in science and even outside the lab environment in real functional
applications.
Although, the terms Machine Learning and Artificial intelligence are commonly mis-
used or misunderstood. As an example, knowledge graphs can be described as an artificial
intelligence tool but are not machine learning. Therefore the machine learning system-
s/algorithms are a subset of artificial intelligence where the system can change itself
when exposed to new data without the need of explicitly program changes or define any
kind of rules [57].
2.5.1 Types
Machine learning techniques can be classified in different categories based on some char-
acteristics [57, 58]:
• Supervised Learning: in this category of machine learning methods, the model is
fed with a group of input sets (X) and the correspondent output (Y ). The objective
20
2.5. MACHINE LEARNING
is to get the mapping function M (or usually an approximation) that correlates the
input variables with the given outputs.
Y =M(X) (2.10)
It can be further divided in two categories, classification models, when the output
variable is categorical, for example "Grade 1 hypertension", "Grade 2 hypertension",
"Normal BP", and so on, and regression models, when the output is a continuous
variable itself, like the BP value.
• Unsupervised Learning: Unlike supervised learning, in this category of machine
learning approaches only the set of features are given to the model, usually be-
cause the labels are not available, with the aim of divide a data set into clusters,
considering their similarities.
• Semi-Supervised Learning: It is a mix between supervised and unsupervised learn-
ing where part of the data is unlabeled.
With this approach, the labeled and unlabeled data can be fed into an clustering
system (unsupervised learning) that label the non-labeled data based on similari-
ties, and then use the resultant data to make predictions of new data (supervised
learning).
• Reinforcement Learning: In this machine learning category trial and error ap-
proaches are used to find a solution to a specific problem. The solver performs
a random action and gets rewards if the result contributes to attain the final objec-
tive or penalties if the opposite happens.
In this work the focus will be supervised learning regression methods and in some
specific points unsupervised learning methods, since the objective is to predict BP values,
that is a continuous variable, based on past observations, that are used to train the model.
2.5.2 Algorithms
The regression algorithms will be discussed in this section, they can be as simple as a
linear regression model or more complex as neural network (NN). There are no master
key model for all problems, the pros and cons of each model should be evaluated and
outcome should be used to define the best model.
2.5.2.1 Linear Regression
The linear regression is the simplest form of regression, the objective is to model a given
training data with a linear function. This way the predicted value results from a linear
combination of the features (equation 2.11).
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yˆ(ω,x) = ω0 +ω1x1 +ω2x2 + ...+ωnxn (2.11)
Where yˆ is the predicted value, x = (x0,x1,x1, ...,xn) comprises the computed features,
ω = (ω1,ω2, ...,ωn) is the coefficients vector, and ω0 is a intercept value.
The objective is to find ω and ω0 that better fits the training data and then make
predictions with each new x. The process of finding the best ω can be achieved based on
cost function J minimization, like ordinary least squares [59].
min(J(Yˆ ,Y )) =min(
1
n
n∑
i=1
(yˆ − y)2) (2.12)
2.5.2.2 Random Forest
The random forest (RF) is an ensemble approach for classification or regression. An
ensemble learning method uses several prediction algorithms with the goal of improving
the overall accuracy of system [59]. In this case, as can be interpreted by the name, a
RF learning method uses decision trees as fundamental structures, thus the decision tree
learning algorithm will be briefly explained in the following paragraphs.
A decision tree is a simple algorithm inspired in the human decision process, and due
to this fact it is usually well understood by users in contrast with black-box algorithms
like NN [59]. The tree is normally constructed from top to bottom where each node
represents a feature, the process can be simplified in some steps:
1. Train data selection;
2. Best feature selection;
3. Split the data according with the possible values of the selected feature (node cre-
ation);
4. Recursively repeat points 2 and 3 with the subset of data that results from the last
point;
5. Stop when stopping criteria is reached.
It is important to explain some of the points above, the feature selection can be pro-
cessed using several criteria, like impurity based, gain ratio, distance measure, among
others. But the core objective is to select the feature that better describes the problem
(figure 2.10). The growth of the tree should also be controlled since a bigger tree is more
prone to suffer from overfitting and takes longer to be trained, several conditions can
be used like the tree maximum depth and maximum leaf nodes. An additional step of
pruning can be made so that unnecessary splits are removed, this process simplifies the
tree and leads to a sub-tree that is less affected by overfitting in the train data.
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(a) High information gain (b) Low information gain
Figure 2.10: Difference in information gain based on the feature selected, it is the amount
of information that is gained by knowing the value of the attribute, which is the entropy
of the distribution before the split minus the entropy of the distribution after it. The
largest information gain is equivalent to the smallest entropy.
Although, trees generally do not have the same level of accuracy as some of the other
regression and classification methods. As a solution, the predictive performance of trees
can be substantially improved using random forests [59].
The improvement can be explained using statistical concepts [60]. Given a set of n
independent observations F = {F1,F2, ...,Fn}, each one with variance σ2, the variance of
the mean of the observations is equal to the mean of the variances.
V (F¯) =
1
n
n∑
i=1
V (Fi) =
σ2
n
(2.13)
The only adaptation that is necessary is to bootstrap (taking repeated samples from
the training data set) since only one training data set is available. This way, using RF,
several decision trees are created, but in contrast with Bagging method, where the trees
are created choosing the best feature in each node from all features, the chosen feature
is selected from a group of a certain number of randomly selected features. This change
improves the decorrelation between trees.
2.5.2.3 Neural Network
The work and investigation with NN results from the understanding of how human brain
works when transforming a complex group of inputs into a simple action or output.
This way, just like the human brain, an artificial NN is a massively parallel distributed
processor, capable of storing experimental knowledge and making it available for feature
use [61]. It consists of several elementary units, called neurons.
A model of a digital neuron based on the McCulloch-Pitts model [62] is represented
in figure 2.12, as well as the tree neuron main components:
• A set of synapses that are characterized by synaptic weights, ωk1,ωk1, ...,ωkm, that
can be seen as the importance of that input to the overall neuron output;
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Training 
Data
Result
Figure 2.11: Random Forest method representation, it operates by constructing a multi-
tude of decision trees at training time and outputting the class that is the mode of the
classes (classification) or mean prediction (regression) of the individual trees.
Figure 2.12: Artificial neuron representation, adapted from [61]
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• A adder function, that adds all input signals weighted by the respective synaptic
strengths;
• And an activation function to limit the amplitude of the neuron output.
It is common to include a bias input to increase or decrease the net input of the
activation function, this helps controlling the activation function [61, 62], allowing to
shift it in the horizontal axis. Usually it is represented as a fixed input of value 1 with
a specific weight equal to the bias. The neuron can be mathematically explained in the
following equations:
vk =
m∑
j=1
ωkjxj + bk (2.14)
yk = φ(vk) (2.15)
Where x1,x2, ...,xm are the inputs, ωk1,ωk2, ...,ωkm are the respective weights, bk is the
bias and φ the activation function.
As mentioned previously, an artificial NN, or commonly just NN, is a combination
of simple neuron units, typically grouped in layers. In figure 2.13 is represented a feed-
forward multi-layer network, where each output of a layer of neurons is fed as input to
each neuron of the next layer, in this network tree different layers can be identified, a
input label that receives the input data, one or more hidden layers where the core of
the computation occurs, and an output layer that converts the activation result in the
hidden layer to an output that can be the class (when the problem is a classification) or
a value (when the output is the result of a regression problem). There are other types of
networks like Radial Basis Functions NN, Recurrent NN, among others, but the scope of
this dissertation will be only the simplest case of NN.
Before it is possible to use a NN to make predictions, it is necessary to train it first.
The training is generally performed giving to the network several examples of inputs for
which the outputs are known, and update the weights using the errors.
A common algorithm to perform this training iteratively is the back-propagation
algorithm. It can be simplified in some steps [61, 63]:
1. Model initialization: The weights are randomly initialized;
2. Foward propagation: Then the input vector is propagated forward through the NN;
3. Loss function: The output values are then compared with the real known values,
this comparison is performed using the chosen loss function, for example, the abso-
lute difference between the calculated values and the real values or more frequently
the sum of squares of the absolute errors;
4. Differentiation: Computation of the loss function gradient, since it gives the rate
with which the function is changing;
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Figure 2.13: Fully-connected multi-layer neural network representation, adapted from
[61]
5. Back propagation of the error: The error values are then propagated backwards
through the network to calculate the error values of the hidden layer neurons. The
loss function gradients of the hidden neurons can be solved using the chain rule;
6. Weights update: The weights are updated using the delta rule [64], defined by:
∆ωji = α(y
∗
j − yj )φ′(hj )xi (2.16)
Where α is a constant (learning rate), φ is the neuron’s activation function, y∗j is the
target output, hj is the weighted sum of the neuron’s inputs, yj the output, and ωij
is the ith input.
7. Iterate: This procedure is repeated until the weights converge.
2.5.2.4 Adaptive Boosting
The adaptive boosting (AdaBoost) is a machine learning algorithm first developed by
Yoav Freund and Robert Schapire. Just like RF, boosting is an approach based on the
idea that several relatively weak and inaccurate rules combined can lead to an highly
accurate prediction rule [59]. The main difference is that the objective here is to create
sequential weak predictors, so that the following predictor uses information from the
present predictor. Adaboost can be resumed in the following points [59]:
1. Adaboost combine multiple weak predictors;
2. The weak predictors are sequentially generated.
3. The instances selected from the training set are not randomly selected, instead
they are chosen based on the relative weights that are updated in each iteration
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(instances that are missclassified have a greater probability of being selected in the
next weak predictor);
4. Each weak predictor is associated to a constant α that is calculated based on how
good that predictor is.
The final result of the predictor is given by equation 2.17
H(x) =
I∑
i=1
αihi(x) (2.17)
Where H is the final hypothesis, αi is the assigned weight associated to the ith weak
predictor hi .
2.5.2.5 Principal Component Analysis
The principal component analysis (PCA) is usually used to reduce the dimensionality of
data sets preserving the most information. This reduction in the number of features can
be used to help visualizing the data, for example when five features are reduced to three
features, these can be plotted and visually analyzed. This method can also be used to
reduce the total number of features used in the training process, so that the computational
needs and training time are reduced.
2.5.3 Evaluation
A crucial characteristic of a machine learning model is how well the model can generalize
to new unseen data. When a trained model cannot deliver the best results when evaluating
new data it is possible that the model is overfitted to the training data.
To evaluate this scenario it is common to divide the data set in two or three groups:
• Training set: The data that will be used to train the machine learning model;
• Validation set: An ’optional’ set that can be used to fine tune the model hyperpa-
rameters (parameters set before the learning process) with new unseen data;
• Test set: A set of unseen examples used only to assess the performance of the model.
One important factor when evaluating a model is to choose a test data set that is rep-
resentative of the data set as a whole and sufficiently large to yield statistically significant
results.
Several metrics can be used to perform the model evaluation, since this work focus on
regression problems, the usual metrics to evaluate the models are:
Were n is the number of samples, y the real value and y∗ the estimated value.
• mean error (ME)
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ME =
1
n
n∑
i=1
y − y∗ (2.18)
• mean absolute error (MAE)
MAE =
1
n
n∑
i=1
|y − y∗| (2.19)
• root mean squared error (RMSE): Sensitive to larger errors
RMSE =
√
1
n
n∑
i=1
(y − y∗)2 (2.20)
• Coefficient of Determinations (R squared): provides indication of how good is the
fit between predictions and actual values.
R2 = 1− SSres
SStot
(2.21)
Where SStot =
∑
i(yi − y¯2), SSres =
∑
i(yi − yˆi)2, yi is the measured value, yˆi the
estimated value, and y¯ the mean value of y.
2.6 Time Series Analysis
The time series analysis domain comprise methods to analyze time series data (set of
observations xt, measured over time t) in order to extract useful information and statistics
from that data.
Time series analysis can be divided in several areas, in the context of this work the
objective will be to measure the similarities between two time defined signals.
2.6.1 Pearson Correlation Coefficient
Although Pearson correlation coefficient is not a specific time series analysis tool, it can
be used to calculate the correlation between two different variables.
It can be calculated with equation 2.22
r =
∑n
i=1(xi − x¯)(yi − y¯)√∑n
i=1(xi − x¯)2
√∑n
i=1(yi − y¯)2
(2.22)
Where n is sample size, xi and yi are the individual sample points of each variable
indexed with i, x¯ and y¯ are the mean of each variable. This coefficient vary between -1
and 1, where 1 is total positive linear correlation, -1 is total negative linear correlation
and 0 is no linear correlation.
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2.6.2 Dynamic Time Warping
The dynamic time warping (DTW) is a algorithm used to measure the similarity between
two temporal sequences A = a1, a2, ..., an and B = b1,b2, ...,bm that can vary in speed, and
works calculating the distance between all points of both series. This results in a n ×m
matrix D where each position is given by Dij = distance(ni ,mj), with i ∈ {0,1, ...,n} ∧ j ∈
{0,1, ...,m} , and then find the optimal path from (0,0) to (n,m), minimising cumulative
distance of the path.
Figure 2.14: DTW representation, adapted from [65], the signals have the same charac-
teristics, but with different velocities
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Blood Pressure Estimation With
biophysical Models
This chapter contains the majority of the information about the materials used to estimate
BP using the biophysical models presented in chapter 2 as well as a complete description
of the methodology.
3.1 State of the Art
In 1981, Gueddes et al. [66] conducted a laboratory experiment in 10 anesthetized dogs,
with the objective of evaluate the relationship between PAT and BP. Two different meth-
ods were used, to calculate PAT, the first one using the signal from two pressure trans-
ducers in different arterial points (in carotid and femoral arteries), and the second one
using ECG and carotid pressure signal. The BP was raised with epinephrine injected
intravenously and lowered with vagal stimulation. The results indicate that the PWV
calculated with PAT increase nearly linearly with BP.
In 2000, Chen et al. [49] proposed a method to estimate BP using PAT and intermittent
re-calibration with 5 minutes period. The BP was estimated by combining two acquired
components, a low frequency component from the intermittent measured BP, and a
high frequency component, that represents the variation of BP between intermittent
BP measurements. This component was obtained by extracting a specific frequency band
from PAT signal. The PAT was determined using the R peak in ECG and the onset
of fingertip PPG sensor, the intra arterial BP was used as reference in both calibration
and test. The study was performed in 20 subjects during cardiovascular surgery. The
mean correlation coefficients between estimated and reference BP was 0.97 with standard
deviation (SD) of 0.02, the RMSE mean value was (3.70 ± 1.85)%, and the mean error was
(0.06 ± 0.68)%.
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In 2005, Poon and Zhang [67] developed a cuffless and noninvasive technique for
measuring BP using PAT (denominated as PTT in the article) based on Moens-Korteweg’s
formula. The data acquisition was performed in 85 subjects (39 hypertensives, 9 with
congestive heart failure and 13 suffering from diabetes mellitus, 37 were healthy subjects),
the protocol consisted in recording ECG, PPG and BP using a conventional mercury
sphygmomanometer, first for calibration procedures and, after that, a set of measures was
performed to evaluate the system. After a period of 1 month the test was repeated. This
approach concluded that PTT-based approach can estimate SBP and DBP within 0.6 ±
9.8 mmHg and 0.9 ± 5.6 mmHg of the reference measurement, respectively.
In 2009, Chen et al. [47] proposed a new mathematical model that relates PWV and
BP. Two PPG (toe and and earlobe) were used to calculate beat-to-beat PTT values, the
BP values were acquired invasively with a pressure transducer inside the radial artery.
In order to avoid individual calibration for each subject, the calibration was performed
for groups of subjects, creating benchmark models for different groups, based on age and
gender. The calibration benchmarks were created using data from 23 subjects, while the
clinical verification of the models was performed in 20 different subjects. The results of
this approach have met the AAMI test standard for DBP, with absolute mean deviation of
1.4 mmHg and SD of 7.5 mmHg, outperforming the auscultatory method. This approach
is only suitable for people who do not have cardiovascular problems, in these cases an
individual calibration process is still necessary.
In 2016, Ding et al. [7] proposed a model that uses not only PTT, but also a new
indicator called photoplethysmogram intensity ratio (PIR), that can be affected by changes
in the arterial diameter, therefore it can be used to track low frequency changes in BP.
The algorithm was evaluated in 27 healthy subjects using the BP data from Finapress as
reference. The proposed model had a MAE of 4.09 mmHg and 3.18 mmHg of SBP and
DBP respectively .
In 2017, Carek et al. [68] developed a watch type device denominated SeismoWatch,
including a PPG sensor (used as distal time reference) and an accelerometer to measure
the thoracic vibrations that mark the heart contraction (proximal time reference). The de-
vice was tested with 13 healthy young subjects, with no history cardiovascular problems.
The acquisition protocol was divided in three phases, first, the subject performed a series
of exercises to vary the BP (used in calibration), second, the system was evaluated one
day after calibration, and finally where a multiple-day test was performed. The group
RMSE was 2.9 mmHg and 4.8 mmHg for DBP and SBP, respectively.
The aim of this chapter is to evaluate different models proposed in several papers
based in the same metrics and data, as well as test the influence of different devices in the
overall accuracy of the system. This represents an important step for future investigations,
since it is impossible to compare previous works between them due to different evaluation
metrics, and protocols.
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3.2 Materials and Methods
3.2.1 Subjects
The subjects characteristics can be found in table 3.1.They were recruited based on con-
venience sampling, and only the subjects capable of performing the requested isometric
leg exercise, were enrolled for the study. None of the subjects underwent cardiovascular
surgery and only one of the 20 selected subjects was previously diagnosed with hyper-
tension (stage 2) and was taking medication at the time to lower the BP (Enalapril 20
mg once a day ). From the 20 subjects and based only on the acquired data in this study,
11 subjects were classified as having normal BP values, 6 as pre-hypertensive, and 2 as
hypertensive stage 1.
Table 3.1: Subjects characteristics
Number of Subjects 20
Gender (M/F) 9/11
Age (Mean ± SD) (29.75 ± 12.17) years
Maximum Age 62 years
Minimum Age 18 years
SBP (Mean [Min;Max]) (123.16 [96;152]) mmHg
DBP (Mean [Min;Max]) (79.69 [64;90]) mmHg
3.2.2 Acquisition Device
Two different devices were used to acquire both ECG and PPG signals, a description of
those devices can be found in table 3.2. The BP values were acquired using an oscillo-
metric automatic device from A&D (UA-651BLE), the full protocol of acquisition can be
found in annex A.
Table 3.2: ECG and PPG acquisition devices
Device A Device B
Device Biosignalsplux Bitalino
Sampling Rate
1000 Hz (capable up to 3000
Hz)
1000 Hz
Resolution 16-bit 10-bit
ECG sensor Gain: 1100 Gain: 1000
PPG sensor
Gain: 34
Wavelength: 670 nm
Transmittance
Gain: -
Wavelength: 565 nm
Reflective
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3.2.3 Data Collection Procedure
Data were collected following a standard protocol at Fraunhofer AICOS offices in Lisbon
and at Postura Ímpar clinic.
The protocol comprises four stages, resulting in four distinct datasets for each subject:
• Calibration set: This dataset includes continuous PPG and ECG signals and se-
quential BP measurements. During the first five BP measurements the subjects
were in rest, and the following while performing a leg extension exercise that was
maintained until reaching muscular fatigue. This exercise leads to a rise in BP [69];
• Static Test set: This set contains three BP measurements with the respective contin-
uous ECG and PPG signals acquired in static mode, without inducing variation in
BP;
• Dynamic Test set: This set contains three BP measurements with the respective con-
tinuous ECG and PPG signals acquired while subject is performing a leg extension
exercise that leads to a rise in BP;
• Follow-up Test set: This set corresponds to a repetition of the Static Test Set and
Dynamic Test Set after not less than one week nor more than two weeks follow-
ing the calibration and initial measurements of each subject. It contains six BP
measurements with the respective continuous ECG and PPG signals.
Due to subject unavailability, the Follow-up Test Set was not collected for three of the
subjects.
3.2.4 Pre-processing and PTT Calculation
Figure 3.1 depicts examples of the ECG and PPG signals acquired with device B. Two
main issues that need pre-processing correction can be identified: the high frequency
noise in the ECG signal, and the PPG signal saturation that mostly happens in device B.
To overcome these issues, a pre-processing phase is necessary to guarantee a good
signal quality and minimise errors in subsequent processing steps. The ECG signal is
filtered in both directions, to remove phase shift, using a digital bandpass finite impulse
response (FIR) filter with low frequency of 0.5 Hz and high frequency of 30 Hz. In PPG
signal, an additional step to interpolate the signal in the saturation zone is performed,
first the saturation zones are detected based on the value of the signal and the respective
analog to digital converter (ADC) maximum value, then it is interpolated using cubic
spline interpolation and the information in a window of 100 ms before and after the
saturation zone. The signal is then filtered in both directions using a digital band-pass FIR
filter with low frequency of 0.5 Hz and high frequency of 3 Hz to remove high frequency
noise.
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Figure 3.1: Raw signals
Figure 3.2: Pre-processed signals
Several works from different authors indicate that the PTT, defined as the time that
the blood takes to travel between two different arteries points, is highly correlates with
the BP. Therefore, the PTT has the potential to be used as BP tracker. As mentioned
in chapter 2, in this work, the R peaks of the ECG signal are used as proximal time
references, and three different points, Figure 3.3 (cycle maximum, start and onset), from
PPG signal are tested as distal time references with the objective of assessing which one
leads to better results.
Maximum
Onset
Start
Figure 3.3: Example of PPG points tested as distal time references in PTT calculation
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Hence, the first step to calculate the PTT signal is to identify the proximal and distal
points in ECG and PPG signals, respectively. The R peaks in the ECG signal are identified
using the algorithm proposed by Hamilton, described in chapter 2 and implemented in
BioSPPy toolbox [70]. An example of he result of the application of this algorithm can be
found in figure 3.4.
0 2 4 6 8 10
Time (s)
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Figure 3.4: Example of the detection of R peaks in an ECG signal using Hamilton R peak
detection algorithm. Green line: EEG signal, red dots: R peaks detected.
The process identification of the three fiducial points in the PPG signal begins with
the identification of the maximum in each cardiac cycle. The process of identifying the
maximum of the PPG in each cardiac cycle can be decomposed in two different phases:
1. Adaptive peak detection: This phase is based on the approach present in HeartPy
module [71]. First, the rolling mean of the PPG signal with a 0.75 seconds window
is calculated. Then, the peaks are identified as the maximum of each portion of the
PPG signal above the rolling mean signal, from the peak location it is possible to
calculate the RR standard deviation (RRSD), and the mean cardiac frequency.
This procedure is repeated several times with different vertical shifted signals based
on the rolling mean signal. The final result are the peaks that result in the lower
non-zero value of RRSD and have cardiac frequency between 40 beats per minute
(BPM) and 180 BPM, used in this stage as physiological limits at rest.
2. Correction: The previous phase is usually enough for a correct identification of most
peaks, although, in very specific situations some errors may occur. To overcome
these errors and get a more robust algorithm the ECG signal is used as a correction
tool. If more than one PPG peak is detected between two consecutive R peaks in
the ECG signal, the peak with the highest amplitude is considered the systolic peak
(maximum), and it is used for PTT calculation. This is especially useful when the
first part of the algorithm erroneously detects both systolic and diastolic peaks,
instead of only systolic peak as it was supposed to.
The other two fiducial points from PPG signal, cycle start and onset, are calculated
relatively to the maximum of the PPG signal, previously identified for each cardiac cycle.
The cycle start is defined as time value corresponding to the minimum of the signal
between two consecutive PPG maxima, and the onset point is defined as the time value
with greater gradient between the cycle start and the maximum of the PPG.
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The PTT is calculated subtracting the proximal and distal time references of the same
cardiac cycle (equations 3.1, 3.2, 3.3). The PTT is considered valid if it falls within the
range [0.2×RR;0.7×RR]
P T Tinit = tinit − trpeak (3.1)
P T Tmax = tmax − trpeak (3.2)
P T Tonset = tonset − trpeak (3.3)
Where trpeak is the ECG R peak location (in time) and the tinit, tmax, tonset are the
location in time of the initial, maximum and onset points on the correspondent PPG
cycle.
An example of the resultant PTT signal can be seen in figure 3.5, in some cases, due to
R peaks misidentification, spurious peaks can be identified in PTT signal. These can be
corrected by performing a median filter with a window size of 3 samples. The resultant
signal of this procedure is represented in figure 3.6.
Figure 3.5: PTT signal pre median filtering
Figure 3.6: PTT signal post median filtering
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3.2.5 Blood Pressure Estimation
As presented in chapter 2 several biophysical models have been proposed to predict BP
from PTT. The main difference between the approach taken in this work and bibliogra-
phy described in the beginning of this chapter is that the calibration procedure is usually
performed using expensive BP meters that give continuous measurements, like the Fi-
nometer, and in this work the calibration is performed using an automatic device that
can be easily used at home.
The models tested in this work were selected from previous works based on their
reported performance, the models with higher performance are compiled in table 3.3.
Table 3.3: Biophysical models used in this work, where A, B and C are subject and model
dependent constants
Model Equation
(1) BP = A · P T T +B
(2) BP = A · logP T T +B
(3) BP = AP T T +B
(4) BP = A · P T T 2 +B
(5) BP = A · P T T 2 +B · P T T +C
(6) BP = A · P T T +B ·HR+C
(7) BP = A · logP T T +B · logHR+C
The calibration needs to be performed for each subject. Since the cuff-based BP mea-
surement does not reflect an instantaneous value of the BP, but rather the BP in a window
of time, the PTT values used for calibration are the mean of the PTT signal in a window
of ten seconds before the BP measurement (figure 3.7).
The pairs (BP, PTT) (or in case of the models that use HR, the triplets (BP, PTT, HR)
are then used to calculate the constants of each model for each subject. This procedure
is performed using ordinary least squares algorithm implemented in scikit-learn [58] for
each SBP and DBP value. In Figure 3.8 is an calibration example from the signal present
in Figure 3.7.
After the constants determination it is possible to estimate the BP values referent to
the new PTT values.
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Static Isometric Exercise Static
Figure 3.7: Subject 09 PTT and BP calibration signals
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BP = -337 PTT + 193
Figure 3.8: Subject 09 linear model calibration example
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3.3 Results
3.3.1 Calibration
The calibration process was performed for each SBP and DBP values. With the objective of
understanding which distal reference point of the PPG cycle led to better results, the cal-
ibration procedure was also performed with the different PTT values (PTTinit, PTTonset,
PTTmax). The results can be observed in Table 3.4.
Table 3.4: All subjects coefficient of determination mean and SD correspondent to SBP
and DBP calibration (Device A)
Model Measure
PTTmax PTTonset PTTinit
R2 SD R2 SD R2 SD
(1)
SBP 0.77 0.16 0.81 0.11 0.40 0.29
DBP 0.72 0.17 0.75 0.14 0.36 0.26
(2)
SBP 0.72 0.17 0.75 0.14 0.35 0.25
DBP 0.77 0.16 0.81 0.11 0.40 0.29
(3)
SBP 0.77 0.15 0.81 0.11 0.38 0.29
DBP 0.72 0.17 0.75 0.14 0.33 0.25
(4)
SBP 0.77 0.16 0.81 0.11 0.41 0.29
DBP 0.72 0.17 0.75 0.14 0.37 0.26
(5)
SBP 0.82 0.16 0.85 0.11 0.49 0.26
DBP 0.75 0.17 0.78 0.14 0.46 0.26
(6)
SBP 0.82 0.13 0.85 0.08 0.72 0.20
DBP 0.78 0.14 0.80 0.12 0.70 0.19
(7)
SBP 0.82 0.13 0.85 0.08 0.71 0.21
DBP 0.78 0.14 0.80 0.12 0.69 0.20
The use of PTTonset leads to higher R2 and lower SD in every model tested, therefore
it was deemed the best distal reference point from PPG cycle for the purpose of estimating
SBP and DBP, and it will be used to compute the all the results in the following sections
of this work.
To evaluate the influence of the device in the BP estimation, the calibration phase is
performed using both devices (A and B) for each subject. The calibration results, using
PTTonset, for devices A (previously presented in Table 3.4) and B can be observed in Table
3.5 and Figure 3.9.
The ANOVA test was used to test the null hypotheses (H0 : µ(1) = µ(2) = ... = µ(7)),
in contrast with the alternative hypothesis H1 where at least one mean is statistically
different from the remaining. Since F = 2.144 < Fcrit = 2.167 (p − value = 0.052 > 0.050),
for SBP, and F = 0.733 < Fcrit = 2.167 (p − value = 0.624 > 0.050), for DBP, the null
hypothesis can not be rejected at the level of significance α = 0.05 . There was not
enough evidence to conclude that the coefficient of determination mean between models
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Table 3.5: Coefficient of determination mean (R2) and SD correspondent to devices A and
B calibration for all subjects
Device Model
SBP DBP
R2 SD R2 SD
A
(1) 0.81 0.11 0.75 0.14
(2) 0.75 0.14 0.81 0.11
(3) 0.81 0.11 0.75 0.14
(4) 0.81 0.11 0.75 0.14
(5) 0.85 0.11 0.78 0.14
(6) 0.85 0.08 0.80 0.12
(7) 0.85 0.08 0.80 0.12
B
(1) 0.52 0.29 0.46 0.26
(2) 0.46 0.25 0.52 0.28
(3) 0.53 0.28 0.47 0.25
(4) 0.51 0.29 0.46 0.26
(5) 0.61 0.27 0.56 0.20
(6) 0.64 0.24 0.65 0.21
(7) 0.65 0.24 0.65 0.20
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(c) SBP (Device B)
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Figure 3.9: Boxplot of the coefficient of determination obtained for calibration of SBP and
DBP in all subjects
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differ for both SBP and DBP. The model (7) presented the highest average coefficient of
determination for both SBP and DBP and devices A and B thus, only the results for this
model will be presented in the following sub-sections.
3.3.2 Static and Dynamic Tests
Table 3.6: Results obtained from data collected in Static and Dynamic tests
Device Model (ME ± SD) (mmHg) (MAE ± SD) (mmHg) RMSE (mmHg) R a
A
SBP 0.1 ± 4.1 2.9 ± 2.9 4.1 0.95
DBP -1.2 ± 3.8 3.1 ± 2.4 4.0 0.91
B
SBP -1.4 ± 5.9 4.3 ± 4.3 6.0 0.90
DBP -2.0 ± 4.3 3.7 ± 3.0 4.7 0.89
a Coefficient of correlation between measured and estimated BP values
Table 3.7: Results obtained from data collected in Static and
Dynamic tests (presented separately for device A)
Test Model (MAE ± SD) (mmHg) RMSE (mmHg)
Static
SBP 2.5 ± 3.0 3.9
DBP 2.7 ± 2.0 3.4
Dynamic
SBP 3.3 ± 2.9 4.4
DBP 3.5 ± 2.7 4.4
The results obtained from the overall data are presented in Table 3.6, the results
are presented separately for static and dynamic test in table 3.7 and Figure 3.10 where
different colors and markers are used to represent different users and test type (static and
dynamic).
From this results, it is possible to understand that the device A led to better results
in both SBP and DBP. This may have been caused by the type of PPG sensor used in the
device B. The wavelength used in this sensor can only evaluate the volume changes in
the most superficial vessels; in cases where the room temperature is slightly lower, the
signal to noise ratio dramatically reduces due to vasoconstriction. This can cause misiden-
tification of the important points in PPG signal. This factor may explain the differences
between both devices. On the table 3.7 where the results are presented separately for
static and dynamic tests, the estimation of the BP in the dynamic test was worse when
compared to the static test, leading to higher MAE and RMSE. This can be caused by the
higher number of BP points referent to static position when compared to the dynamic
position in the calibration process, since the isometric exercise is only performed until
fatigue.
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(a) Device A (SBP) (b) Device B (SBP)
(c) Device A (DBP) (d) Device B (DBP)
Figure 3.10: Results after calibration. Each color represents different subjects. Bullet
points represent data from static test and crosses represent data from dynamic test
3.3.3 Follow-up Test
The calibration was re-tested in a follow-up test, with dataset acquired after a period of
time between one and two weeks from the first acquisition. The main objective of this
follow-up test was to infer how well the calibration can hold its capability of estimation
the BP. The results of this test can be found in Figure 3.11 and Table 3.8.
These results indicate that the calibration for each subject loose quality over time, and,
due to this factor, an eventual re-calibration is necessary if the objective is to perform
long term BP estimations.
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Table 3.8: Follow-up Test results obtained from data collected in Static and Dynamic
tests
Device Model ME ± SD (mmHg) MAE ± SD (mmHg) RMSE (mmHg) R a
A
SBP 1.8 ± 6.7 4.3 ± 4.5 6.0 0.90
DBP -2.4 ± 5.9 5.2 ± 3.7 9.2 0.76
B
SBP -1.3 ± 9.2 7.8 ± 5.0 9.3 0.81
DBP -3.5 ± 6.7 6.1 ± 4.4 7.5 0.69
a Coefficient of correlation between measured and estimated BP values
(a) Device A (SBP) (b) Device B (SBP)
(c) Device A (DBP) (d) Device B (DBP)
Figure 3.11: Follow-up Test results. Each color represents different subjects. Bullet points
represent data from static test. Crosses represent data from dynamic test
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3.4 Discussion
The direct comparison between different scientific works is not always possible, since
different authors evaluate their systems based in different metrics and test protocols. In
this work the results were evaluated following as much as possible the Standard IEEE
1708-2014, this standard was created in order to standardize the evaluation of these
devices.
Table 3.9: Machine learning comparison (SBP)
Studies MAE ± SD (mmHg) RMSE (mmHg)
This Work 2.9 ± 2.9 4.1
Chen et al. [47] - -
Ding et al. [7] 4.09 ± - -
Carek et al. [68] - 2.9
Table 3.10: Machine learning comparison (DBP)
Studies MAE ± SD (mmHg) RMSE (mmHg)
This Work 3.1 ± 2.4 4.0
Chen et al. [47] 1.4 ± - 7.5
Ding et al. [7] 3.18 ± - -
Carek et al. [68] - 4.8
In the implemented method used to estimate the BP using biophysical models, the
calibration was performed with an automatic oscillometric device instead of using an
invasive method, like in the approach tested by Chen et al., or manual measurements
using a conventional mercury sphygmomanometer. This enabled the scalability of the
system for final users and can be adapted for ambulatory scenarios. Another difference
is the exercise performed in the calibration procedure (isometric leg exercise). In most
studies, the BP was varied by medication or via cardiovascular based exercises, that
implies a large amount of subject motion, leading to low quality signals and impossibility
to be performed in subjects that suffer from motor difficulties. The system was evaluated
following as much as possible with the criteria presented in IEEE Standard for Wearable
Cuffless Blood Pressure Measuring Devices [72]. As previously mentioned, since the
ground truth for BP in the studies presented in tables 3.9 and 3.10 are not homogeneous,
a direct performance comparison between the method tested in this work and the methods
in bibliography is limited. However, it is possible to conclude that the developed work
had a similar performance when compared to other studies [7, 47, 68].
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Table 3.11: ANSI/AAMI SP10 and Standard 1708-2014 evaluation criteria [72, 73]
MAE (mmHg) ANSI/AAMI SP10 Recommended grade
≤ 5 pass A
5 - 6 pass or fail B
6 - 7 mostly fail, less pass C
≥ 7 fail D
Using all data as indicated in the standard (static test, test with BP change from the
calibration point, and test after a certain period of time from calibration), both devices
(A and B) were classified with recommended grade A if used right after calibration.
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Blood Pressure Estimation Using Machine
Learning
To overcome some of the BP estimation disadvantages using the method presented in
chapter 3, like the need of calibration and re-calibration, a different approach, using
machine learning methods, is presented and explained in this chapter. This part of the
work was developed as a proof of concept using a public dataset.
4.1 State of the Art
Several studies have been published recently reporting the use machine learning methods
to estimate BP.
In 2013, Kurylyak et al. [74] used an Artificial NN and a set of 21 features, including
HR, the times of systolic and diastolic parts of the PPG cycle, as well as different widths
at different heights, extracted from subjects present in medical information mart for
intensive care (MIMIC) database. In total, 15000 PPG cycles with the corresponding BP
values were used, although there are no information about how many subjects were used.
The training and test sets were randomly selected based on instances (70% for training,
15% for validation and 15% for testing). This approach had a MAE of 3.80 ± 3.46 mmHg
for SBP and 2.21 ± 2.09 mmHg for DBP.
In 2017, Kachuee et al. [75] proposed a framework to estimate the BP through two
types of features from the ECG and PPG signals, physiological parameters, like PAT based
features, HR and inflection point area ratio, and whole-based features, that are features
that result from parsing a window containing various cardiac cycles. A total of 10 features
from roughly 1000 unique subjects from MIMIC II database were used to train/test five
different learners (linear regression, decision tree, support vector machine, AdaBoost and
RF). This framework had a MAE ± SD of 11.17 ± 10.09 mmHg and 5.35 ± 6.14 mmHg for
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SBP using RF (best performance learner in the study). An additional step of calibration
was added to the calibration-free method, which improved the results to 8.21 ± 5.45
mmHg and 4.31 ± 3.52 mmHg MAE ± SD, respectively. No considerations were made
about PPG/ECG desynchronization.
In 2018, Wang et al. [76] proposed a method based only in PPG extracted features.
The features were extracted using the multitaper method, and the BP estimation was
performed using an NN. A total number of 72 subjects from MIMIC database were used
in this approach, the PPG signals of each subject were divided by cycle, and a total of
22 features were calculated for each cycle, two morphological features (systolic upstroke
time and diastolic time) and twenty spectral features (extracted using multitaper method).
The data was randomly split in 70% of the instances for training, 15% for validation and
15% for testing. The proposed method results in mean differences between the estimated
and measured BP, of -0.0217 ± 4.8950 mmHg for SBP and 0.0975 ± 2.9160 for DBP, and
MAE of 4.02 ± 2.79 mmHg and 2.27 ± 1.82 mmHg for both SBP and DBP respectively.
In the same year, Radha et al. [77] tested a method to estimate SBP based in long-
and short term memory networks (LSTM), dense networks, RF and linear regression
models. Features based on heart rate variability and pulse morphology were extracted
from the PPG signal, and used to train the models. The models were trained and tested
using a custom dataset acquired at Philips Research laboratory. A total of 110 healthy
volunteers aged between 18 and 65 years, were asked to wear a wrist band containing a
green PPG sensor and a triaxial accelerometer, as well as a clinically validated ambulatory
BP monitor. A total of 226 days of PPG data, and 6629 valid reference BP measurements
were acquired. The results demonstrated that the RF with 32 trees outperformed the other
tested models with a RMSE of 7.86 ± 1.57 mmHg for SBP, in DBP the dense network with
8 perceptrons had slightly better results, with RMSE of 6.49 ± 1.59 mmHg. Contrary to
what was done in the other presented studies, the split between the training/test sets was
performed by subject.
4.2 Materials and Methods
The process of estimating the BP using machine learning is similar to the process that uses
biophysical models. Some core differences should be noted, first, since the process of data
acquisition cannot be controlled, the acquired signals can be affected by intense noise,
motion artifacts and portions of the data where one or more signals are not available, a pre-
processing phase was implemented with the aim of overcoming these problems. Other
core difference is the data used to train the machine learning models, in the approach
using biophysical models the BP is measured using a common oscillometric device that
results in low frequency measurements, in contrast to the intra-arterial BP data used in
the approach presented in this chapter that can be used to identify the BP in each heart
cycle.
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4.2.1 MIMIC III Database
The MIMIC III is a freely available database that contains data from 53 423 distinct
hospital admissions for adult patients (+16 years old) who stayed in critical care units of
the Beth Israel Deaconess Medical Center in Boston, Massachusetts, between 2001 and
2012 [78, 79].
The database contains a variety of information, like hourly measurements of vital
signs, lab test results, medical procedures, medications, mortality information, and other
types of information. A subset of patients also contains several physiological signals
(MIMIC-III Waveform Database), in some cases during hours, such as ECG, PPG, intra
arterial BP, among others. These signals were acquired from bedside monitors, and
not all signals are available for all of the subjects in this subset. A full description of
the collection procedure and the hardware used is not available, but since all data were
collected in medical environment, it is expected that they have been collected using
standard medical protocols and hardware, this way, it is expected that the PPG signal
was acquired in the finger and the intra arterial BP with a transducer inside the radial
artery. It is also important to note that only a small portion of the MIMIC-III Waveform
Database are linked to the MIMIC III, because of that, most of the data does not have
information about subject’s age and gender. In addition, due to privacy concerns subjects
with more than 89 years of age were shifted to hide their true age and comply with HIPAA
regulations [78]. It is neither possible to ensure an alignment inter-signals. The waveform
data contains unknown filtering delays and/or unknown inter-channel delays, which may
not be constant at a given record and between different subjects. This limitation makes it
impossible to use inter-signals features.
In this work, due to hardware limitations, mostly memory size constrains, a random
subset of 1156 patients, containing ECG, PPG and BP signals, was selected from MIMIC-
III Waveform Database.
The SBP and DBP histograms from the selected subset of data can be found in the
Figure 4.1.
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Figure 4.1: Histogram of the BP data for the 1156 patients randomly selected from MIMIC
III database
4.2.2 Pre-processing
First the PPG and ECG signals are filtered using the same procedure described in chapter
3, to remove high frequency noise. The BP signal is kept unfiltered since this process
influence the amplitude values of the signal.
4.2.2.1 BP Signal Cleaning
The BP signal is divided in windows of 5 seconds, and the maximum (that corresponds
to the maximum SBP) and the minimum (that corresponds to the minimum DBP) of each
window is calculated. The windows where the parameters do not meet the physiological
limit values are removed, this allows the removal of portions of the signal where the
pressure suddenly rises due to subject movement. Those parameters were defined as [80]:
• 60 mmHg < Maximum SBP < 220 mmHg;
• 30 mmHg < Maximum DBP < 150 mmHg;
• SBP - DBP > 20 mmHg.
4.2.2.2 PPG and ECG hard Noise Cleaning
The process of cleaning both PPG and ECG signals is based on the periodicity of these
signals in time, and the procedure is the same for both signals.
The portion of the signal inside a 5 second sliding window is used to calculate the
autocorrelation signal. Two output examples are represented in figures 4.2 and 4.3.
It is possible to observe that, since the ECG and PPG signals are relatively periodic,
the autocorrelation signal does not have a significant decrease for lower values of lag.
Conversely, in signals affected by severe noise, small values of lag lead to higher decrease
in the autocorrelation signal.
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Figure 4.2: Good quality PPG Signal and respective autocorrelation signal
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Figure 4.3: Noisy PPG Signal and respective autocorrelation signal
The signal is removed if the autocorrelation coefficient with a lag of 8 samples is lower
than 0.85. This values were used based on empirical observations.
4.2.2.3 Template Cleaning
Although the signals are relatively free of high frequency intense noise at this stage, some
zones of the signal can have low quality segments due to factors like motion artifacts and
momentary poor conductivity between the surface of the body and the sensor. This way,
a robust method to detect and remove the zones with lower quality signal is necessary.
It was achieved based on a template creation and comparison technique, in this section
it is described with the PPG signal, but is equally used with the ECG. The process can be
described as:
1. Fiducial Point Detection: The first part of the process is to identify the points
that mark the beginning of the PPG cycle (a complete description can be found in
chapter 3).
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Figure 4.4: PPG signal and detected starting points of each cycle
2. Template Creation: A 30 seconds sliding windows with an overlap of 1 second is
then used to calculate the PPG template. It is calculated as the mean of all cycles
detected in that windows (one for each beginning point detected in the fidutial
point detection phase). For simplification all cycles are considered to have the same
length on that window, equal to the lag associated with the first maximum of the
autocorrelation signal.
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Figure 4.5: 30 seconds window PPG cycles and generated template
3. Cycle/Template Comparison: Each cycle on the windows is compared with the
window template using the Pearson correlation coefficient to measure the similarity
between cycles, and using the correlation between time-warped cycles (that result
from DTW) and the template. A threshold of 0.9, defined empirically, is used to
determine if the PPG cycles have good quality, the cycles with coefficients lower
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than 0.9 are discarded. If more than 50% of the cycles are considered bad quality
cycles, the entire window is removed.
This approach results in a trade off between signal quality fed into the regression
model and the frequency of new BP estimations. The 30 seconds window was empirically
chosen so that the portion of the 30 seconds window contains enough cardiac cycles
to create the template, maintaining, however, a relatively high measurement frequency
when compared with the current methods. An example of this pre-processing phase can
be seen in image 4.6.
Figure 4.6: Pre-processing phase example
4.2.3 Features Extraction
Several features are selected from ECG and PPG signals, a brief explanation of each
feature can be seen in table 4.1. The presented features are calculated for each PPG cycle,
associated with the respective SBP and DBP and vertically scaled between 0 and 1.
The time series feature extraction library (TSFEL) is a feature extraction library devel-
oped by Fraunhofer AICOS with the objective of assist researchers on exploratory feature
extraction tasks on time series 1. It is used in this work to automatically extracts more
than 50 different features on the statistical, temporal and spectral domains (Table 4.2).
1Avalible in github.com/fraunhoferportugal/tsfel
2f (t) = a1e
−( t−a2a3 )2 + b1e
−( t−b2b3 )
2
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Table 4.1: Used Features
Signal Feature Description
ECG RR
time between R peaks of the present cycle and the previous
cycle
PPG t1 time between the start and the onset points of the cycle
PPG t2 time between the start and the maximum points of the cycle
PPG t3 time between the start and the final points of the cycle
PPG t4
time between the maximum of the cycle and the minimum
gradient between the maximum and the end of the cycle
PPG t5
time between the maximum of the cycle and the minimum
gradient between the maximum and the end of the cycle
PPG t6
time between the maximum of the cycle and the maximum of
the second order gradient between the maximum and the end
of the cycle
PPG Atotal total area under the cycle curve
PPG A1
ratio between the area under the curve between the starting
point and the onset point, and the total area
PPG A2
ratio between the area under the curve between the starting
point and the maximum point, and the total area
PPG A3
ratio between the area under the curve between the maximum
point and the end point, and the total area
PPG
a1, a2, a3 constants of the function f (t) 2 fitted to the cycle
b1,b2,b3
PPG W25 width 25% hight
PPG W50 width 50% hight
PPG W75 width 75% hight
PPG + Features from TSFEL
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Table 4.2: TSFEL features examples
Domain Feature Description
Statistical
Skewness
measures the asymmetry of the signal distribu-
tion
Kurtosis
measures the distribution shape around a nor-
mal distribution
Histogram
plots the number of members for each bin
against a total given number of bins
Mean measures the signal arithmetic mean
Variance measures the dispersion of the signal value
Standard Deviation measures the dispersion of the signal values
Interquartile Range
computes the difference between the upper and
lower quartile
Temporal
Max computes the signal maximum value
Min computes the signal minimum value
Centroid
computes the arithmetic mean position of all
the signal points
Root Mean Square
computes the square root of the arithmetic
mean of the square of the signal values
Median Absolute Deviation
computes the median distance between each
data value and the signal median value
Zero Crossing Rate
computes the rate at which the signal sign
changes
Autocorrelation
computes the correlation of a signal with a
lagged version of itself
Linear Regression computes the linear regression of the signal
Spectral
Max Frequency
computes where the FFT reaches its 95% of dis-
tribution
Median Frequency
computes where the FFT reaches its 50% of dis-
tribution
Fundamental Frequency
computes the frequency corresponding to the
greatest common divisor of all the frequency
components in the signal
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Max Power Spectrum
computes the maximum value of the power
spectrum density along a given axis
Total Energy
computes the total energy of the signal given by
the squared sum of the spectral coefficients nor-
malised by the length of the sample windows
Spectral Centroid
computes the weighted mean position of the sig-
nal frequencies distribution and their probabil-
ity
Spectral Spread
measures the variance of the signal frequencies
asymmetry distribution
Spectral Skewness
measures the asymmetry of the signal frequen-
cies distribution
Spectral Kurtosis
measures the signal frequencies distribution
shape around a normal distribution
Spectral Slope
measures how quickly the spectrum decreases
towards the high frequencies
Spectral Decrease
measures the decrease on the spectral ampli-
tude though its linear regression computation
Spectral Roll On
computes the frequency so that 5% of the signal
energy is contained below of this value
Spectral Roll Off
computes the frequency so that 95% of the sig-
nal energy is contained below of this value
Curve Distance
computes the euclidean distance of the signal’s
cumulative sum of the FFT elements to the lin-
ear regression
Spectral Variation
computes the spectral variance from the cross-
correlation of two consecutive amplitude spec-
tra
Some feature from TSFEL have no relevance in the context of this work, one example
is the maximum of the cycle. Since the cycle is always scaled between 0 and 1, and the
amplitude of the PPG can vary depending on hardware factors, this feature does not add
any information. This way the features with zero variance are removed.
4.2.4 Machine Learning
The calculated features are used to train three machine learning models implemented in
Scikit-learn [58], a NN, a AdaBoost, and a RF.
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Since the objective is to predict the BP in new users without a calibration phase, the
dataset is split based on users, instead of instances. Following this premise the dataset
is divided in 7 groups of 152 subjects (for 7-fold cross-validation) with a total of 1064
subjects, this represents that nearly 14% of the data is used as testing set. This is in
line with the recommended values by the literature [81] of between 10% and 20%. The
training is performed with 6 groups and the remaining group is reserved for testing, the
procedure is repeated until every group is used as testing set, the output result is the
mean of all iterations.
An intermediate phase of feature scaling (to mean zero and unit variance) is also
performed, because methods like NN are sensitive to the input data magnitude. This
phase should be executed separately in the test and training group, so there is no leak of
information (mean and standard deviation) between the sets.
The last step before training the models is dimensionality reduction using PCA al-
gorithm. The objective is to understand whether the PCA use leads to an indirect im-
provement, due to faster convergence to the solution, caused by the reduction on the
number of features. The number of principal components is selected based on the desired
cumulative explained variance (95% in this work).
4.3 Results
The use of PCA algorithm led to a 3.6 times faster training phase, but it did not contribute
to the accuracy improvement, which is considered the main objective. In both tests, before
and after PCA, the NN performed better in estimating SBP and DBP (Table 4.3 and 4.4)
with a MAE of 3.59 ± 4.29 mmHg and 2.02 ± 2.50 mmHg, respectively. It is also possible
to observe that, in contrast with the BP estimation using biophysical models, the system
performed better at estimating DBP rather then SBP.
Table 4.3: Results before PCA
Model
SBP DBP
MAE ± SD (mmHg) RMSE (mmHg) MAE ± SD (mmHg) RMSE (mmHg)
NN 3.6 ± 4.3 5.6 2.0 ± 2.5 3.2
RF 4.3 ± 4.6 6.3 2.3 ± 2.6 3.4
AdaBoost 12.2 ± 8.2 14.8 8.8 ± 5.4 10.4
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Figure 4.7: Cumulative explained variance as a function of number of components, the
number of principal components (18) is selected based on the desired cumulative ex-
plained variance (95%)
Table 4.4: Results after PCA
Model
SBP DBP
MAE ± SD (mmHg) RMSE (mmHg) MAE ± SD (mmHg) RMSE (mmHg)
NN 5.1 ± 5.1 7.2 2.7 ± 2.9 4.0
RF 5.1 ± 5.4 7.4 2.7 ± 3.0 4.1
AdaBoost 13.5 ± 9.1 16.3 7.7 ± 4.9 9.2
The results indicate that the method presented in this chapter is capable of estimate
BP without the requirements associated with the use of biophysical models to estimate
BP, like the need of a calibration process to each user
4.4 Discussion
The approach presented in this chapter cannot be evaluated using the same grading
system, since the data used cannot be controlled in terms of BP variations. Although,
several studies have used the same database or previous versions, facilitating the process
of comparison between them. The proposed method had lower mean absolute error for
both SBP and DBP, when compared with other works (Table 4.5 and 4.6).
It is important to note that only in the studies performed by Radha et al., Kachuee
et al., and in this work, the splitting between training and test sets was made based on
subjects, instead of instances. The splitting based on instances lead to better results, but
it is a weaker evaluator, because instances from the same subject can be used both for
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training and testing.
Table 4.5: Machine learning comparison (SBP)
Studies MAE ± SD (mmHg) RMSE (mmHg)
This Work 3.6± 4.3 5.6
Kurylyak et al. [74] 3.80 ± 3.46 -
Kachuee et al. [75] 11.17 ± 10.09 -
Wang et al. [76] 4.02 ± 2.79 -
Radha et al. [77] - 7.86
Table 4.6: Machine learning comparison (DBP)
Studies MAE ± SD (mmHg) RMSE (mmHg)
This Work 2.0 ± 2.5 3.2
Kurylyak et al. [74] 2.21 ± 2.09 -
Kachuee et al. [75] 5.35 ± 6.14 -
Wang et al. [76] 2.27 ± 1.82 -
Radha et al. [77] - 6.49
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Conclusion
In order to optimize the cuffless BP measurements in the future, and understand the
advantages and disadvantages of the methods developed in this work, it is important to
compare them with previous works in the field, as well as proposed future changes than
can lead to better results or a better system.
5.1 Overall discussion and Conclusions
Hypertension is a significant risk factor in several cardiovascular diseases, it is estimated
that 13% of the world’s deaths are directly or indirectly linked to this condition. The
current methods to measure BP, such as oscillometric devices, have some disadvantages,
that hinder the correct BP measurement in ambulatory conditions, during sleep, exercise,
or when continuous values are needed.
This work was developed with the main objective of developing a method that could
be used to measure BP without the usual cuff used in the current standard devices.
Two different solutions were proposed for estimating BP from ECG and PPG signals,
one based in biophysical models and the other using machine learning methods.
The first approach uses biophysical modelling of the arterial blood flow to estimate
BP. The developed system can be described in four stages, first the physiological signals
are pre-processed, with the objective of removing high frequency noise and correct zones
of the PPG signal where the sensor saturate. Then the PTT is calculated using as time
reference the R peaks from ECG (proximal reference), and different points from PPG
(distal references). The use of the pair (PPG, ECG) to calculate PTT makes the process
more robust, when compared with (PPG,PPG) configuration or equivalent, because PPG
signal can be hard to acquire in some locations, like in extremely warm or cold environ-
ments, and it is greatly affected by motion artifacts. The third phase is the calibration of
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the system using the pairs (PTT, BP), the calibration is performed individually for each
subject, and then the BP can be estimated using the new PTT values and the calibrated
model.
This process was performed in parallel with two different devices, and for seven
different models previously proposed in the literature [49–56], in a total of 20 subjects
in laboratory conditions. To evaluate the proposed method a test dataset was acquired
for each subject, this dataset includes three measurements in seated static position, three
measurements performing an isometric exercise to vary the BP, and a repetition of both
two weeks later, resulting in a total of 12 test points for subject. This was made based
in the indications present in the IEEE Standard for Wearable Cuffless Blood Pressure
Measuring Devices.
It was possible to take some valuable conclusions from this approach, first the re-
sults indicate that it is possible to successfully estimate BP using just PTT following a
calibration procedure. I was also observed that the calibration looses quality over time,
due to variations in physiological constants, like arteries Young’s modulus, precluding
the application of this approach for long periods of time without performing regular
re-calibrations. The comparison of the results between the two tested devices indicates
that the used hardware plays an important role in the system accuracy, an example is the
type of PPG sensor (transmittance versus reflectance). Although the reflectance version
of the sensor is more versatile because it can be used in location like the wrist, the resul-
tant signal is heavily affected by superficial arteries vasoconstriction in lower ambient
temperatures, leading to worse results.
The second approach is based on application of machine learning techniques to a
large publicly available database of physiological signals from ICU patients, with the
objective of overcoming some of the limitations inherent to the previous method, such as
the necessity of calibration and re-calibrations.
In contrast to the first approach, where was possible to acquire the needed data, the
use of a clinical database implies some added difficulties, such as, the higher presence
of noise and motion artifacts, and the possibility that not all of the signals are available
for all patients and the whole duration of the record. This creates the need for additional
data pre-processing steps, namely three different pre-processment stages were applied,
first the portion of data where the BP signal had impossible physiological values due to
subject motion while acquiring the intra arterial BP (e.g SBP > 220 mmHg) was removed,
then the portions with high noise were identified and removed using the autocorrelation
signal. The final step was to select only the high quality cycles from ECG and PPG, i.e
the cycles that are not influenced by motion artifacts, and other conditions that change
the general shape of the cycles. This is achieved by comparing each cycle with a template
calculated using all cycles in a windows of time. The resultant signals were then used
to calculate the a total of 58 features, and used to train three different machine learning
methods.
The results indicate that the proposed method can be successfully used to estimate
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BP, outperforming the similar studies, this shows the potential of this technology in the
current field.
It is possible to conclude that both approaches have the potential to be used to solve
the proposed problem of measuring the BP without the cuff need. However, there is a
fundamental difference between them that should be noted and can influence the fields
of application of the presented solutions. While the approach using biophysical models
requires an initial process of calibration and future re-calibrations to maintain the accu-
racy over time, the solution using machine learning methods does not use any calibration
phase, it makes the system more ready to use, with the potential to be used in passive
health monitoring systems, like smartwatches. While the first solution can be used during
hospitalization to estimate the BP between the already performed periodic traditional
measurements of BP.
It is also important to mention that there are some limitations that may have influ-
enced the results, the accuracy of the first approach are highly influenced by the accuracy
of the traditional device to measure the BP, and by the perfect synchronisation between
the acquired signals (ECG and PPG) and the BP values. Due to this factor it is crucial
to ensure the quality of the used material and the synchronization between data, so that
the results are consistent. In the second study it is important to identify the lack of in-
formation about the sensors used to acquire the signals, and the impossibility of ensure
intra-subject variability of BP for a more robust training phase.
5.2 Future Work
Although the developed work shows promising results, some additional investigation
and changes are foreseen to improve it.
In the first approach the system can be simplified in a more compact and ready to use
system, this would allow a more comfortable and fast process of data acquisition in envi-
ronments outside the lab, contributing to a higher variety in the acquired data. Changes
can also be performed in the signal pre-processment stage, similar to the equivalent stage
in the second approach using machine learning, this will make the overall system more
robust, and better adapted for real world scenarios.
The second approach has more room for future improvements, since it is a recent
method in bibliography, and was developed mainly as a proof of concept in this work.
First, and to complement the work performed, a validation step should be performed, to
fine tune the hyperparameters of the different machine learning models. The proposed
method can also be adapted to work with the type of data acquired in the first approach
using, for example, transfer learning. It would be interesting to test if similar results
can be obtained using non-invasive and low frequency BP measurements, which could
make the process of custom made database acquisition easier. The method can also be
easily adapted to work only with the PPG signal, since the ECG signal is only used in this
work to correct PPG fiducial points, and to calculate only one feature. With this small
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change, a future final device can be more user-friendly and be adapted as a watch type
device. Future works can also explore the developments in the deep learning field, and
apply it to test approaches that use deep learning to select the portions of the signals
with enough quality to be used to estimate the BP, or/and use it to remove the feature
extraction phase.
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